Peptides
AssigneeAlergenetica Sl
InventorsNigel Stuart Dunn-Coleman, Maria R. Diaz-Torres, Brian Miller
Life of this patent
Estimating the term…
Abstract
The application discloses peptides capable of preventing or treating fungal disease, including fungal allergy disease.
Claims26
A peptide having an amino acid length of from 8 to 50 amino acids that is selected from (a) a peptide consisting of or comprising the amino acid sequence of one of SEQ ID NOs:10, 196-210, or one of SEQ ID NOs:11, 211-233, or one of SEQ ID NOs:1-9, 12-195, 234-913, and (b) a peptide having a contiguous amino acid sequence having at least 70% sequence identity to the amino acid sequence of one of SEQ ID NOs:10, 196-210, or one of SEQ ID NOs:11, 211-233, or one of SEQ ID NOs:1-9, 12-195, 234-913.
(canceled)
A peptide comprising the amino acid sequence of one of SEQ ID NOs:10, 11, 1-9, 12-58, or a peptide having a contiguous amino acid sequence having at least 80% sequence identity to the amino acid sequence of one of SEQ ID NOs:10, 11, 1-9, 12-58, wherein the peptide has an amino acid length of from 8 to 50 amino acids.
(canceled)
A peptide consisting of the amino acid sequence set forth in one of:
- (i) SEQ ID NO:
- 10 or SEQ ID NOs:
- 196-210;
- (ii) SEQ ID NO:
- 11 or SEQ ID NOs:
- 211-233;
- (iii) SEQ ID NO:
- 1 or SEQ ID NOs:
- 59-80;
- (iv) SEQ ID NO:
- 2 or SEQ ID NOs:
- 81-92;
- (v) SEQ ID NO:
- 3 or SEQ ID NOs:
- 93-105;
- (vi) SEQ ID NO:
- 4 or SEQ ID NOs:
- 106-120;
- (vii) SEQ ID NO:
- 5 or SEQ ID NOs:
- 121-135;
- (viii) SEQ ID NO:
- 6 or SEQ ID NOs:
- 136-150;
- (ix) SEQ ID NO:
- 7 or SEQ ID NOs:
- 151-165;
- (x) SEQ ID NO:
- 8 or SEQ ID NOs:
- 166-180;
- (xi) SEQ ID NO:
- 9 or SEQ ID NOs:
- 181-195;
- (xii) SEQ ID NO:
- 12 or SEQ ID NOs:
- 234-248;
- (xiii) SEQ ID NO:
- 13 or SEQ ID NOs:
- 249-263;
- (xiv) SEQ ID NO:
- 14 or SEQ ID NOs:
- 264-278;
- (xv) SEQ ID NO:
- 15 or SEQ ID NOs:
- 279-293;
- (xvi) SEQ ID NO:
- 16 or SEQ ID NOs:
- 294-307;
- (xvii) SEQ ID NO:
- 17 or SEQ ID NOs:
- 308-317;
- (xviii) SEQ ID NO:
- 18 or SEQ ID NOs:
- 318-332;
- (xix) SEQ ID NO:
- 19 or SEQ ID NOs:
- 333-347;
- (xx) SEQ ID NO:
- 20 or SEQ ID NOs:
- 348-362;
- (xxi) SEQ ID NO:
- 21 or SEQ ID NOs:
- 363-377;
- (xxii) SEQ ID NO:
- 22 or SEQ ID NOs:
- 378-392;
- (xxiii) SEQ ID NO:
- 23 or SEQ ID NOs:
- 393-407;
- (xxiv) SEQ ID NO:
- 24 or SEQ ID NOs:
- 408-422;
- (xxv) SEQ ID NO:
- 25 or SEQ ID NOs:
- 423-437;
- (xxvi) SEQ ID NO:
- 26 or SEQ ID NOs:
- 438-452;
- (xxvii) SEQ ID NO:
- 27 or SEQ ID NOs:
- 453-467;
- (xxviii) SEQ ID NO:
- 28 or SEQ ID NOs:
- 468-482;
- (xxix) SEQ ID NO:
- 29 or SEQ ID NOs:
- 483-497;
- (xxx) SEQ ID NO:
- 30 or SEQ ID NOs:
- 498-512;
- (xxxi) SEQ ID NO:
- 31 or SEQ ID NOs:
- 513-527;
- (xxxii) SEQ ID NO:
- 32 or SEQ ID NOs:
- 528-542;
- (xxxiii) SEQ ID NO:
- 33 or SEQ ID NOs:
- 543-557;
- (xxxiv) SEQ ID NO:
- 34 or SEQ ID NOs:
- 558-572;
- (xxxv) SEQ ID NO:
- 35 or SEQ ID NOs:
- 573-587;
- (xxxvi) SEQ ID NO:
- 36 or SEQ ID NOs:
- 588-602;
- (xxxvii) SEQ ID NO:
- 37 or SEQ ID NOs:
- 603-617;
- (xxxviii) SEQ ID NO:
- 38 or SEQ ID NOs:
- 618-632;
- (xxxix) SEQ ID NO:
- 39 or SEQ ID NOs:
- 633-647;
- (xl) SEQ ID NO:
- 40 or SEQ ID NOs:
- 648-662;
- (xli) SEQ ID NO:
- 41 or SEQ ID NOs:
- 667-681;
- (xlii) SEQ ID NO:
- 42 or SEQ ID NOs:
- 682-696;
- (xliii) SEQ ID NO:
- 43 or SEQ ID NOs:
- 697-711;
- (xliv) SEQ ID NO:
- 44 or SEQ ID NOs:
- 712-717;
- (xlv) SEQ ID NO:
- 45 or SEQ ID NOs:
- 718-723;
- (xlvi) SEQ ID NO:
- 46 or SEQ ID NOs:
- 724-738;
- (xlvii) SEQ ID NO:
- 47 or SEQ ID NOs:
- 739-753;
- (xlviii) SEQ ID NO:
- 48 or SEQ ID NOs:
- 754-768;
- (xlix) SEQ ID NO:
- 49 or SEQ ID NOs:
- 769-783;
- (l) SEQ ID NO:
- 50 or SEQ ID NOs:
- 784-798;
- (li) SEQ ID NO:
- 51 or SEQ ID NOs:
- 799-813;
- (lii) SEQ ID NO:
- 52 or SEQ ID NOs:
- 814-828;
- (liii) SEQ ID NO:
- 53 or SEQ ID NOs:
- 829-843;
- (liv) SEQ ID NO:
- 54 or SEQ ID NOs:
- 844-862;
- (lv) SEQ ID NO:
- 55 or SEQ ID NOs:
- 863-877;
- (lvi) SEQ ID NO:
- 56 or SEQ ID NOs:
- 878-892;
- (lvii) SEQ ID NO:
- 57 or SEQ ID NOs:
- 893-898;
- and
- (lviii) SEQ ID NO:
- 58 or SEQ ID NOs:
- 899-913.
(canceled)
-16. (canceled)
A method of identifying a peptide that is capable of stimulating an immune response, the method comprising:
- testing a candidate peptide for an ability to induce an immune response, said candidate peptide comprising a contiguous amino acid sequence having at least 70% sequence identity to the amino acid sequence set forth in one of SEQ ID NOs:10, 196-210, or one of SEQ ID NOs:11, 211-233, or one of SEQ ID NOs:1-9, 12-195, 234-913, wherein the candidate peptide has an amino acid length of from 8 to 50 amino acids.
Dependencies are inferred from the claim text.